ALK1 signaling regulates early postnatal lymphatic vessel development

In vertebrates, endothelial cells form 2 hierarchical tubular networks, the blood vessels and the lymphatic vessels. Despite the difference in their structure and function and genetic programs that dictate their morphogenesis, common signaling pathways have been recognized that regulate both vascula...

Full description

Saved in:
Bibliographic Details
Published inBlood Vol. 115; no. 8; pp. 1654 - 1661
Main Authors Niessen, Kyle, Zhang, Gu, Ridgway, John Brady, Chen, Hao, Yan, Minhong
Format Journal Article
LanguageEnglish
Published Washington, DC Elsevier Inc 25.02.2010
Americain Society of Hematology
American Society of Hematology
SeriesVascular Biology
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In vertebrates, endothelial cells form 2 hierarchical tubular networks, the blood vessels and the lymphatic vessels. Despite the difference in their structure and function and genetic programs that dictate their morphogenesis, common signaling pathways have been recognized that regulate both vascular systems. ALK1 is a member of the transforming growth factor-β type I family of receptors, and compelling genetic evidence suggests its essential role in regulating blood vascular development. Here we report that ALK1 signaling is intimately involved in lymphatic development. Lymphatic endothelial cells express key components of the ALK1 pathway and respond robustly to ALK1 ligand stimulation in vitro. Blockade of ALK1 signaling results in defective lymphatic development in multiple organs of neonatal mice. We find that ALK1 signaling regulates the differentiation of lymphatic endothelial cells to influence the lymphatic vascular development and remodeling. Furthermore, simultaneous inhibition of ALK1 pathway increases apoptosis in lymphatic vessels caused by blockade of VEGFR3 signaling. Thus, our study reveals a novel aspect of ALK1 signaling in regulating lymphatic development and suggests that targeting ALK1 pathway might provide additional control of lymphangiogenesis in human diseases.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
K.N. and G.Z. contributed equally to this work.
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2009-07-235655